Pembrolizumab in Early Triple-Negative Breast Cancer. Ganguly S, Gogia A. N Engl J Med 2022;386:1771.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ganguly S, Gogia A. Pembrolizumab in Early Triple-Negative Breast Cancer. N Engl J Med 2022;386:1771.
PMID: 35507497